Market Research Logo

United States Pharmaceuticals and Healthcare Report Q2 2015

United States Pharmaceuticals and Healthcare Report Q2 2015

BMI View: The US pharmaceutical market's status as the most lucrative globally is unassailable. This is due to unparalleled healthcare access, considerable spending power, a high burden of disease, minimal market access barriers and intense company activity. The key risks to this positive outlook are the increasing influence of pharmacy benefit managers and greater regulation, such as the Branded Prescription Drug Fee.

Headline Expenditure Projections

Pharmaceuticals: USD361.2bn in 2014 to USD372.8bn in 2015; 3.2%growth. Forecast revised upwards from Q115.

Healthcare: USD3,099bn in 2014 to USD3,261bn in 2015; +5.2% growth. Forecast unchanged from Q115.


BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (United States 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (United States 2011-2019)
Table: Number Of Dispensed Prescriptions By Therapy Area In The US (mn)
Table: Number Of Dispensed Prescriptions By Active Ingredient In The US (mn)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (United States 2011-2019)
Table: Leading Patented Medicines By Non-Discounted Sales In The US (USDbn)
Table: Leading Therapeutic Classes By Non-Discounted Sales (USDbn)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (United States 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (United States 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (United States 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Table: Economic Activity (United States 2010-2019)
Industry Risk Reward Ratings
Americas Risk/Reward Index
United States Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
Table: Key Features Of The Affordable Care Act By Year
Impact Of The Sequester
Research And Development
Clinical Trials
Contract/Clinical Research Organisations
Hospital Sector
Table: Healthcare Sector Data
Regulatory Development
Intellectual Property Regulations
Pricing And Reimbursement Environment
Late-2013 Government Shutdown
Competitive Landscape
Pharmaceutical Sector
Pharmaceutical Distribution
Company Profile
Pfizer
Merck
Eli Lilly
Amgen
GlaxoSmithKline
AstraZeneca
Demographic Forecast
Table: Population Headline Indicators (United States 1990-2025)
Table: Key Population Ratios (United States 1990-2025)
Table: Urban/Rural Population & Life Expectancy (United States 1990-2025)
Table: Population By Age Group (United States 1990-2025)
Table: Population By Age Group % (United States 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report